|
Volumn 94, Issue C, 2010, Pages 35-66
|
Patents
|
Author keywords
[No Author keywords available]
|
Indexed keywords
2 (5 CHLORO 2 METHYL 1H INDOL 3 YL) N,N DIMETHYLETHYLAMINE 5 CHLORO 2 METHYL N,N DIMETHYLTRYPTAMINE;
3 (3 FLUOROPHENYLSULFONYL) 8 (4[11 C]METHYLPIPERAZIN 1 YL)QUINOLINE;
3 PHENYLSULFONYL 8 (1 PIPERAZINYL)QUINOLINE;
AVN 211;
AVN 322;
AVN 457;
AVN 458;
AVN 492;
AVN 502;
DIMEBON;
GSK 215083;
N,N DIMETHYL 3 [3 (NAPHTHALEN 1 YLSULFONYL) 1H INDAZOL 5 YLOXY]PROPAN 1 AMINE;
PF 01913539;
PF 5212365;
SAM 531;
SEROTONIN AGONIST;
SEROTONIN ANTAGONIST;
SGS 518;
SUVN 501;
SUVN 504;
SUVN 507;
SYN 114;
SYN 120;
UNCLASSIFIED DRUG;
WAY 262531;
ALLERGY;
ALZHEIMER DISEASE;
ANXIETY DISORDER;
BOOK;
CLINICAL TRIAL;
COGNITIVE DEFECT;
DEMENTIA;
DEPRESSION;
DRUG APPROVAL;
DRUG INDICATION;
DRUG INFORMATION;
DRUG MECHANISM;
DRUG RESEARCH;
DRUG STRUCTURE;
HUMAN;
HUNTINGTON CHOREA;
LEGAL PROCEDURE;
MEDICAL LITERATURE;
NONHUMAN;
OBESITY;
PATENT;
PRIORITY JOURNAL;
PUBLICATION;
RHINITIS;
SCHIZOPHRENIA;
|
EID: 78349286933
PISSN: 00747742
EISSN: None
Source Type: Book Series
DOI: 10.1016/B978-0-12-384976-2.00002-2 Document Type: Chapter |
Times cited : (9)
|
References (3)
|